Inghams (ASX:ING) share price sinks as Omicron bites

Inghams shares are down as COVID hurts its operations.

| More on:
A woman looks quizzical as she looks at a graph of the share market.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Inghams Group Ltd (ASX: ING) share price is falling, down 7% in early trading, after the poultry company told the market that the Omicron COVID variant is impacting its operations.

A couple of months ago, the business told investors that lockdowns and global COVID effects were a key feature of early FY22 and were causing challenges. But the rapid spread of the Omicron variant is now causing substantial effects too.

Omicron impacts operations and Inghams share price

There were four areas that Inghams updated the market about.

First, the large amount of COVID transmission in the eastern Australian states from December 2021 is resulting in staff shortages. This is now also having an impact on the Australian supply chain, operations, logistics, and sales performance of the ASX share, as well as affecting some suppliers and customers. Management re-iterated there are disruptions to production and distribution capability, as well as an impact on sales.

Second, however, the company has managed to keep all of its major Australian sites operational and it hasn't experienced any "significant" on-site transmission of COVID. But, those sites are currently experiencing significantly lower levels of staff availability. This is impacting production volumes and operational efficiency.

To combat this, Inghams' third message was that operational changes are being made to volume and mix across the Australian business. The company said it isn't possible for management to predict how long this disruption will continue for. It is "premature" to draw any conclusions on the overall impacts on the business and trading results.

Finally, Inghams noted that feed costs continue to remain elevated.

The Inghams share price had drifted lower after the company's operational update in early November 2021 which included a warning on higher feed costs.

However, it was noted that both the federal and state governments recently changed isolation rules for close contacts in the food sector which should help alleviate some of the current staff shortages. It's expecting production capacity to recover relatively quickly to meet demand.

Management commentary

Noting the difficulties, the Inghams CEO and managing director Andrew Reeves said:

The operational and trading difficulties have resulted in significant operational inefficiency, additional costs and the temporary suspension of a number of Ingham's products. Ingham's is working closely with our customers and we are focused on supplying as much product as possible to customers while the current disruption continues.

The company continues to manage the cumulative impacts associated with COVID issues which have arisen through FY22. We will continue to closely manage our working capital and inventory and seek to implement initiatives to minimise the financial and other impacts of COVID through the second half.

Inghams share price snapshot

Prior to today's announcement, Inghams shares had fallen 15% over the past four months. Only part of that decline came after the November 2021 AGM update. Now it is down around 22% in four months.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Broker Notes

These ASX shares could rise 20% to 50%

Analysts are tipping these shares to rise strongly over the next 12 months.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A view of competitors in a running event, some wearing number bibs, line up together on a starting line looking ahead as if to start a race.
Technology Shares

Here's how the ASX 200 market sectors stacked up last week

ASX technology shares led the market with a 2.48% increase last week.

Read more »

A father helps his son look through binoculars during a family holiday or day out in the city.
Opinions

Up 190% in a year, why I think Life360 shares can keep soaring higher

This tech stock has plenty of potential.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

3 small-cap ASX healthcare shares 'with strong prospects'

Fund manager IML discusses why these 3 ASX healthcare shares are likely to rise in value.

Read more »

Magnifying glass on a rising interest rate graph.
Share Market News

Will the RBA finally cut interest rates next week?

Let's see what economists are saying about the central bank's meeting.

Read more »

A couple sits on a sofa, each clutching their heads in horror and disbelief, while looking at a laptop screen.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors endured a rough Friday to close the trading week today.

Read more »

a man wearing old fashioned aviator cap and goggles emerges from the top of a cannon pointed towards the sky. He is holding a phone and taking a selfie.
Broker Notes

7 ASX All Ords shares elevated to 'strong buy' status in October

The brokers turned bullish on these ASX companies last month.

Read more »